|
Originally published In Press as doi:10.1074/jbc.M704089200 on August 25, 2007
J. Biol. Chem., Vol. 282, Issue 44, 32384-32396, November 2, 2007
Mapping the Binding Site on Small Ankyrin 1 for Obscurin*
Maegen A. Borzok ,
Dawn H. Catino 1,
James D. Nicholson¶,
Aikaterini Kontrogianni-Konstantopoulos 2, and
Robert J. Bloch 3
From the
Departments of Biochemistry and Molecular Biology and Physiology and the ¶Program in Neuroscience, University of Maryland, School of Medicine, Baltimore, Maryland 21201
Small ankyrin 1 (sAnk1), an integral protein of the sarcoplasmic reticulum encoded by the ANK1 gene, binds with nanomolar affinity to the C terminus of obscurin, a giant protein surrounding the contractile apparatus in striated muscle. We used site-directed mutagenesis to characterize the binding site on sAnk1, specifically addressing the role of two putative amphipathic, positively charged helices. We measured binding qualitatively by blot overlay assays and quantitatively by surface plasmon resonance and showed that both positively charged sequences are required for activity. We showed further that substitution of a lysine or arginine with an alanine or glutamate located at the same position along either of the two putative helices has similar inhibitory or stimulatory effects on binding and that the effects of a particular mutation depended on the position of the mutated amino acid in each helix. We modeled the structure of the binding region of sAnk1 by homology with ankyrin repeats of human Notch1, which have a similar pattern of charged and hydrophobic residues. Our modeling suggested that each of the two positively charged sequences forms pairs of amphipathic, anti-parallel -helices flanked by -hairpin-like turns. Most of the residues in homologous positions along each helical unit have similar, though not identical, orientations. CD spectroscopy confirmed the -helical content of sAnk1, 33%, predicted by the model. Thus, structural and mutational studies of the binding region on sAnk1 for obscurin suggest that it consists of two ankyrin repeats with very similar structures.
Received for publication, May 17, 2007
, and in revised form, July 31, 2007.
* This work was supported by National Institutes of Health Grant R01 HL64304 (to R. J. B.) and Grant R01 AR52768 (to A. K. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Table S1.
1 Current address: MedImmune, Gaithersburg, MD 20878.
2 Current address: Dept. of Biochemistry and Molecular Biology, University of Maryland, School of Medicine, Baltimore, MD 21201.
3 To whom correspondence should be addressed: Dept. of Physiology, University of Maryland, School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201. Tel.: 410-706-3020; Fax: 410-706-8341; E-mail: rbloch{at}umaryland.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Ackermann, L.-Y. R. Hu, A. L. Bowman, R. J. Bloch, and A. Kontrogianni-Konstantopoulos
Obscurin Interacts with a Novel Isoform of MyBP-C Slow at the Periphery of the Sarcomeric M-Band and Regulates Thick Filament Assembly
Mol. Biol. Cell,
June 15, 2009;
20(12):
2963 - 2978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Cunha and P. J. Mohler
Obscurin Targets Ankyrin-B and Protein Phosphatase 2A to the Cardiac M-line
J. Biol. Chem.,
November 14, 2008;
283(46):
31968 - 31980.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|